Home > Diabetes and Endocrinology MDTV > Fish oil, dash diet...

Fish oil, dash diet partially alters lipid metabolism

By - Dr. Nandita Mohan
Published On 2021-12-13 00:41 GMT   |   Update On 2021-12-15 05:44 GMT

Type 2 diabetes is associated with elevated levels of metabolic abnormalities and systemic inflammation, with an increased risk of developing cardiovascular diseases (CVDs) diseases. A recent study suggests that fish oil intervention with a dietary approach to stop hypertension (DASH) had partial alteration on lipid metabolism and inflammatory mediators. The study findings were presented at...

Login or Register to read the full article
Register Now

Type 2 diabetes is associated with elevated levels of metabolic abnormalities and systemic inflammation, with an increased risk of developing cardiovascular diseases (CVDs) diseases. A recent study suggests that fish oil intervention with a dietary approach to stop hypertension (DASH) had partial alteration on lipid metabolism and inflammatory mediators. The study findings were presented at the Metabolic Institute of America (TMIOA) 2021 World Congress Insulin Resistance Diabetes & Cardiovascular Disease (WCIRDC) Meeting.

Omega-3 fatty acids contain two long-chain fats: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are found in oily fish. Recent studies demonstrated the effects of EPA and DHA on the risk of developing cardiovascular disease. To further evaluate Dr Fasail Ali and team hypothesized that altering the macronutrient composition of diets in patients with diabetes might alter metabolic and inflammatory abnormalities. They conducted a study to evaluate the changes in plasma lipid profile and identify potential inflammatory mediators following the DASH diet and the omega-3 capsules supplementation.
For more details check out the full story in link below:

Fish Oil & DASH Diet Partially Alters Lipid Metabolism, Not Glycemic Control Or Adiposity


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Food additive emulsifiers linked to increased risk of type 2 diabetes, finds study
Avocado may help lower diabetes risk in women, finds study
Does yoghurt help in prevention of diabetes and obesity?
Is there a difference in gut microbiome of prediabetic patients? Study sheds light
Do newly diagnosed type 2 diabetics succeed in weight management?
Can a low-fat vegan diet reduce insulin requirement in type 1 diabetes?
Debunking Myths: Addressing Concerns of Borderline Diabetes - Dr Nagappa H Handargal
The Truth About Carbohydrates in Diabetes: Dispelling Misconceptions - Dr Sheethal N Kumar